Home » Topics » BioWorld Science

BioWorld Science
RSS

Preliminary phase I results for dolastatin 10 in advanced solid tumors

May 13, 1997

Animal and human pharmacokinetics of 9-NC reported

May 13, 1997

Oral toxicity of SarCNU in rats

May 13, 1997

CRF receptor antagonist from Pfizer active in animal model of depression

May 13, 1997

Preclinical and preliminary clinical studies on flavopiridol

May 13, 1997

Preclinical characterization of aplidine

May 13, 1997

Prevention of breast cancer with Targretin

May 13, 1997

Menarini prepares new NNRTIs with potent anti-HIV activity

May 13, 1997

Orally active FdUrd derivative prepared at Taiho

May 13, 1997

Pfizer and Oncogene characterize EGF receptor TK inhibitor

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...